A New Biological Input Layer for AI-Powered Presymptomatic Therapy
GBS makes subclinical disease actionable—detecting plasma misfolding early and translating it into protocolized clinical next steps. We enable longitudinal tracking and structural remediation before irreversible damage occurs.